Introducing personalised healthcare to stratify patient groups and ensure everyone gets the best, most appropriate care is seen as a cost, but actually it is an opportunity to have a fitter and more productive population, and to develop new companies, new products and new markets.
But times are hard, and the stumbling block is building a convincing argument for investing in the development and implementation of personalised healthcare at a time when governments across Europe are slashing budgets. “We can’t ask for more money,” said Alexander von Gabain, Chairman of the European Institute of Innovation and Technology (EIT).
Instead, it is necessary to be more innovative in how the available cash is spent and to put greater effort into leveraging the value of existing public spending on research. “We’ve got to get everyone in the ecosystem to work together,” von Gabain told delegates at the Science|Business conference, ‘Personalised Healthcare: from Theory to Practice’ in London last week (26 Jan).
To read the full, original article click on this link: Science|Business - The media network for research, industry and policy
